Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
MicroRNA targets, genetic variation and schizophrenia expression in 22q11.2 deletion syndrome
FY 2020-21
Summary
About 1 in 3000 people are born with a piece of genetic information (DNA) missing from one copy of their chromosome 22. Individuals with this disorder, called 22q11.2 deletion syndrome (22q11.2DS), are about 20 times more likely to develop schizophrenia (SCZ), a severe psychiatric illness. Having a 22q11.2 deletion leads to a reduction in a class of small molecules called microRNAs (miRNAs), which help turn off other genes. Multiple genetic factors are believed to be important in causing SCZ, and changes to miRNA levels may be a critical link in the cascade of events that lead to SCZ. Genetic variation includes structural changes (copy number variants or CNVs) and changes at a single building block of DNA (single nucleotide variants or SNVs). Scientists have proposed that a reduction in miRNAs may cause genetic variants that are normally tolerated to increase risk for expressing an illness. We think that the lower levels of miRNAs in 22q11.2DS could therefore increase the potential for expression of SCZ. We will use DNA sequencing data from people with 22q11.2DS to study this. We predict that in those with SCZ, compared to those with no SCZ, there will be a higher proportion of CNVs and SNVs that affect the gene targets of the miRNAs that are reduced in 22q11.2DS. We will assess the significant findings using data from general population SCZ samples from international repositories. Identifying genetic changes that lead to SCZ and are involved in a miRNA mechanism in 22q11.2DS may help explain why individuals with 22q11.2DS are at such a high risk to develop SCZ. Most importantly, a miRNA mechanism could lead to a better understanding about SCZ in general, and could lay the foundation for developing new therapies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449674
Name
Ying Sheng Jie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
MicroRNA targets, genetic variation and schizophrenia expression in 22q11.2 deletion syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
22q11.2 Deletion Syndrome; Copy Number Variants (Cnvs); Dgcr8; Digeorge Syndrome; Gene Expression; Genetics; Microrna; Schizophrenia; Single Nucleotide Variants (Snvs); Whole Genome Sequencing
Abstract
About 1 in 3000 people are born with a piece of genetic information (DNA) missing from one copy of their chromosome 22. Individuals with this disorder, called 22q11.2 deletion syndrome (22q11.2DS), are about 20 times more likely to develop schizophrenia (SCZ), a severe psychiatric illness. Having a 22q11.2 deletion leads to a reduction in a class of small molecules called microRNAs (miRNAs), which help turn off other genes. Multiple genetic factors are believed to be important in causing SCZ, and changes to miRNA levels may be a critical link in the cascade of events that lead to SCZ. Genetic variation includes structural changes (copy number variants or CNVs) and changes at a single building block of DNA (single nucleotide variants or SNVs). Scientists have proposed that a reduction in miRNAs may cause genetic variants that are normally tolerated to increase risk for expressing an illness. We think that the lower levels of miRNAs in 22q11.2DS could therefore increase the potential for expression of SCZ. We will use DNA sequencing data from people with 22q11.2DS to study this. We predict that in those with SCZ, compared to those with no SCZ, there will be a higher proportion of CNVs and SNVs that affect the gene targets of the miRNAs that are reduced in 22q11.2DS. We will assess the significant findings using data from general population SCZ samples from international repositories. Identifying genetic changes that lead to SCZ and are involved in a miRNA mechanism in 22q11.2DS may help explain why individuals with 22q11.2DS are at such a high risk to develop SCZ. Most importantly, a miRNA mechanism could lead to a better understanding about SCZ in general, and could lay the foundation for developing new therapies.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ying, Sheng Jie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~